Last updated on September 2018

Using Cardiovascular Magnetic Resonance Tissue Characterisation and Wearable Technology to PREDICT Clinical Outcomes Response to Therapy and Arrhythmias in Hospitalised Heart Failure Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Diffuse Fibrosis | Arrhythmia | Focal Fibrosis | Heart failure
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18
  • First hospital admission with a diagnosis of HF (as defined below)
  • Able and willing to provide informed consent
  • Able to undergo CMR

Exclusion Criteria:

  • Known or subsequent diagnosis of amyloidosis, sarcoidosis or hypertrophic cardiomyopathy
  • Severe valve disease of any type requiring inpatient surgery
  • Heart transplant recipient or admitted for cardiac transplantation/ left ventricular assist device
  • Clinically apparent myocardial ischemia which requires revascularisation
  • Myocardial infarction or revascularisation within the previous 60 days
  • Intra cardiac mass which requires surgery
  • Active endocarditis
  • Septicaemia
  • Pregnancy
  • Life expectancy <2 years secondary to any other cause (i.e. malignancy)
  • Active treatment with chemotherapy
  • Severe renal failure (GFR <30)

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.